Artroniq Berhad (0038.KL)

MYR 0.08

(7.14%)

EBITDA Summary of Artroniq Berhad

Artroniq Berhad's latest annual EBITDA in 2023 was -695 Thousand MYR , up 86.46% from previous year.
Artroniq Berhad's latest quarterly EBITDA in 2023 Q4 was 520 Thousand MYR , up 132.93% from previous quarter.
Artroniq Berhad reported an annual EBITDA of -5.13 Million MYR in 2022, down -388.56% from previous year.
Artroniq Berhad reported an annual EBITDA of 1.57 Million MYR in 2021, up 172.7% from previous year.
Artroniq Berhad reported a quarterly EBITDA of 479 Thousand MYR for 2023 Q1, up 103.04% from previous quarter.
Artroniq Berhad reported a quarterly EBITDA of 520 Thousand MYR for 2023 Q4, up 132.93% from previous quarter.

Annual EBITDA Chart of Artroniq Berhad (2023 - 2019)

Historical Annual EBITDA of Artroniq Berhad (2023 - 2019)

Year	EBITDA	EBITDA Growth
2023	-695 Thousand MYR	86.46%
2022	-5.13 Million MYR	-388.56%
2021	1.57 Million MYR	172.7%
2020	-2.44 Million MYR	-409.59%
2019	790.36 Thousand MYR	0.0%

Year	EBITDA	EBITDA Growth
2023 Q2	439 Thousand MYR	-8.35%
2023 Q1	479 Thousand MYR	103.04%
2023 Q4	520 Thousand MYR	132.93%
2023 Q3	-1.57 Million MYR	-459.68%
2022 Q2	2.26 Million MYR	62.9%
2022 Q1	1.39 Million MYR	0.0%
2022 FY	- MYR	-388.56%
2022 Q4	-15.76 Million MYR	-594.71%
2022 Q3	3.18 Million MYR	40.64%
2021 FY	- MYR	172.7%
2020 FY	- MYR	-409.59%
2019 FY	- MYR	0.0%

Peer EBITDA Comparison of Artroniq Berhad

Name	EBITDA	EBITDA Difference
QES Group Berhad	33.26 Million MYR	102.089%
Optimax Holdings Berhad	28.58 Million MYR	102.431%
Pharmaniaga Berhad	7.34 Million MYR	109.458%
Apex Healthcare Berhad	441.93 Million MYR	100.157%